See better Q2 for Infy; buy HDFC Bank: India Nivesh Sec

Daljeet Singh Kohli, India Nivesh Securities in an interview to CNBC-TV18 shared his views on stock specific bets like Infosys, HDFC Bank and the pharma space.The house, he said, has a buy rating on Infosys with a target price of Rs 1188. According to him all the new initiatives and hard work undertaken by the new management is now bearing fruit. The company has a lot of catch up to do and with the Q1 earnings now beating estimates; it has shown that it would soon be able to come back to industry level growth.Kohli expects better performance of Infosys to continue in Q2 as well and thinks it is a good time to accumulate on the stock.The house also has a buy rating on HDFC Bank with a target price of Rs 1265. According to him the bank has been a consistent performer and has never surprised on the negative. He expects a 20 percent topline growth.One has to be stock specific with regards to midcap pharma space. He likes Torrent Pharma, and also Alembic Pharma, where the US growth has been better. From an industrial recovery perspective he prefers Pennar Industries.Disclosures: Stocks that we mentioned, I do not own any of these stocks but we have recommended these stocks so promoters, directors, clients may have positions in them.